12:00 PM EDT, 07/16/2024 (MT Newswires) -- AngioDynamics ( ANGO ) shares were up more than 20% in recent Tuesday trading after the medical technology company reported a smaller-than-expected fiscal Q4 loss and announced a $15 million share repurchase program.

The company posted a fiscal Q4 adjusted loss of $0.06 per diluted share, compared with earnings of $0.02 a year earlier.

Three analysts polled by Capital IQ expected a loss of $0.17.

Net sales for the quarter ended May 31 fell to $71 million from $91.1 million a year earlier.

Three analysts surveyed by Capital IQ expected $70.9 million.

For fiscal 2025, the company expects an adjusted loss of $0.38 to $0.42 per share on net sales of $282 million to $288 million.

Three analysts polled by Capital IQ expect a loss of $0.49 on revenue of $287.7 million.

AngioDynamics ( ANGO ) said its board approved a $15 million stock repurchase program.

Price: 7.14, Change: +1.21, Percent Change: +20.40